Pramodini Medicare IPO
Pramodini Medicare IPO
Overview
Pramodini Medicare IPO is a book build issue of ₹69.04 crores. The issue is a combination of fresh issue of 0.54 crore shares aggregating to ₹63.14 crores and offer for sale of 0.05 crore shares aggregating to ₹5.90 crores. Pramodini Medicare IPO opens for subscription on Aug 12, 2026 and closes on Aug 14, 2026. The allotment for the Pramodini Medicare IPO is expected to be finalized on Aug 17, 2026. Pramodini Medicare IPO will list on the NSE SME with a tentative listing date fixed as Aug 19, 2026. Pramodini Medicare IPO is set issue price band at ₹110 to ₹118 per share. The lot size for an application is 1,200 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,83,200 (2,400 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,600 shares), amounting to ₹4,24,800. Smart Horizon Capital Advisors Pvt.Ltd. is the book running lead managerand Purva Sharegistry (India) Pvt.Ltd. is the registrar of the issue. The Market Maker of the company areRainbow Securities Pvt.Ltd., Shreni Shares Ltd.
Total Shares
58,51,200
Issue Size
₹69 Cr
Price Band
₹110 – ₹118
Lot Size
1200 shares
Min. Investment
₹1,41,600
Max. Investment
₹1,41,600
Open Date
12 Aug, 2026
Close Date
14 Aug, 2026
Allotment
17 Aug, 2026
Listing
19 Aug, 2026
Max. Investment
₹1,41,600
Announced
12 Aug, 2026
Opening Date
12 Aug, 2026
Closing Date
14 Aug, 2026
Basis of Allotment
17 Aug, 2026
Initiation of Refunds
18 Aug, 2026
Credit of Shares
18 Aug, 2026
Listing Date
19 Aug, 2026
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Pramodini Medicare IPO
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities.
Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound wi
Pramodini Medicare IPO Share Price
Issue Breakdown
Shareholding
Dilution: 32.1% increase in shares
Pramodini Medicare IPO Financial Health
Pramodini Medicare Ltd.'s revenue increased by 64% and profit after tax (PAT) rose by 56% between the financial year ending with March 31, 2026 and March 31, 2025.
Pramodini Medicare IPO Lot Size
Investors can bid for a minimum of 2,400 shares and in multiples of 1,200 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 2400 | ₹2,83,200 |
| Individual investors (IND) (Max) | 2 | 2400 | ₹2,83,200 |
| S-HNI (Min) | 3 | 3600 | ₹4,24,800 |
| S-HNI (Max) | 7 | 8400 | ₹9,91,200 |
| B-HNI (Min) | 8 | 9600 | ₹11,32,800 |
(All values in CR)
Pramodini Medicare IPO Valuations
| Metric | Value |
|---|---|
| ROE | 39.08 |
| ROCE | 34.66 |
| Debt/Equity | 0.34 |
| RoNW | 32.69 |
| PAT Margin | 27.90 |
| EBITDA Margin | 49.61 |
| NAV | 31.84 |
| Price to Book Value | 3.71 |
(All values in CR)
Pramodini Medicare IPO Strength & Risk
Pramodini Medicare IPO Strengths
- Diversified diagnostic services portfolio across radiology, pathology and nuclear medicine.
- Strategic presence across multiple states and cities in India.
- Asset-light business model supported by PPP and partnership arrangements.
- Strong technical capabilities backed by robust IT infrastructure.
- Experienced management team with significant healthcare industry expertise.
- Strong recent financial performance, with FY26 revenue and profit showing substantial growth.
Pramodini Medicare IPO Risks
- Significant dependence on government authorities through Public-Private Partnership (PPP) arrangements for revenue.
- High concentration in radiology services exposes the company to segment-specific risks.
- Changes or termination of government contracts could adversely affect revenue and profitability.
- Diagnostic operations depend on expensive medical equipment, making maintenance and technology upgrades important.
- Expansion into new locations may involve execution risks and could take time to generate expected returns.
- As an SME IPO, the stock may face relatively higher liquidity and price-volatility risks after listing.
Pramodini Medicare IPO GMP
Last updated 05 Aug, 2026 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 05 Aug, 2026 | 0 | ₹0 | - | ₹ (0.00%) | - | 05 Aug, 2026 |
| 04 Aug, 2026 | 0 | ₹0 | - | ₹ (%) | - | 04 Aug, 2026 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Pramodini Medicare IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Pramodini Medicare IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.